NUKV — Nuclear Vision Income Statement
0.000.00%
- CA$9.05m
- CA$8.04m
Annual income statement for Nuclear Vision, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Total Operating Expenses | 0.206 | 0.584 | 0.244 | 0.554 |
| Operating Profit | -0.206 | -0.584 | -0.244 | -0.554 |
| Net Income Before Taxes | -0.206 | -0.584 | -0.244 | -0.554 |
| Net Income After Taxes | -0.206 | -0.584 | -0.244 | -0.554 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -0.206 | -0.584 | -0.244 | -0.554 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -0.206 | -0.584 | -0.244 | -0.554 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.014 | -0.041 | -0.017 | -0.031 |
| Dividends per Share |